mercaptoethanol has been researched along with Cancer of Cervix in 6 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide/mesna has activity in a wide range of gynecologic malignancies." | 1.28 | Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies. ( Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP, 1990) |
| "Ifosfamide/mesna has activity in a wide range of gynecologic malignancies." | 1.28 | Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies. ( Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP, 1989) |
| "Ifosfamide and mesna were administered to 77 patients with advanced malignancies." | 1.27 | Prediction of ifosfamide/mesna associated encephalopathy. ( Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervellino, JC | 1 |
| Araujo, CE | 1 |
| Pirisi, C | 1 |
| Sanchez, O | 1 |
| Brosto, M | 1 |
| Rossi, R | 1 |
| Sutton, GP | 2 |
| Blessing, JA | 2 |
| Photopulos, G | 2 |
| Berman, ML | 2 |
| Homesley, HD | 2 |
| Meanwell, CA | 1 |
| Blake, AE | 1 |
| Kelly, KA | 1 |
| Honigsberger, L | 1 |
| Blackledge, G | 1 |
| Kvarnfors, P | 1 |
| Svehag, SE | 1 |
| Koffler, D | 1 |
| Carr, R | 1 |
| Agnello, V | 1 |
| Thoburn, R | 1 |
| Kunkel, HG | 1 |
6 other studies available for mercaptoethanol and Cancer of Cervix
| Article | Year |
|---|---|
Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Humans; Ifo | 1990 |
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
Topics: Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesn | 1990 |
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Ci | 1989 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Huma | 1986 |
Antibody formation in cell cultures. 2. The effect of rabbit peritoneal exudate cells on secondary in vitro IgG and IgM antibody responses to poliovirus.
Topics: Animals; Antibody Formation; Cell Line; Centrifugation, Density Gradient; Culture Techniques; Female | 1971 |
Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.
Topics: Animals; Antibodies, Antinuclear; Antibody Specificity; Antigens; Antigens, Bacterial; Antigens, Vir | 1971 |